Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Oxford Immunotec is a global, high-growth diagnostics company dedicated to developing and commercializing proprietary tests for the management of immune-regulated conditions. Its flagship product, the T-SPOT®.TB test, is a leading method for diagnosing Tuberculosis (TB) infection by measuring T-cell immune response. The company's innovative T-cell measurement technology also finds applications in other areas of immunology, contributing to improved patient care. Since January 2021, Oxford Immunotec has operated as part of PerkinElmer, Inc., benefiting from enhanced global reach, resources, and R&D capabilities within the broader diagnostics landscape.
The UK headquarters serves as the primary center for research and development of its T-SPOT technology, global operations management, manufacturing, and key corporate functions.
Located within Milton Park, one of Europe's largest science, technology, and business parks, the headquarters benefits from state-of-the-art laboratory and office facilities, fostering an environment of innovation and collaboration.
The work culture at Oxford Immunotec emphasizes scientific rigor, innovation, and a strong commitment to improving patient outcomes through advanced diagnostic solutions. As part of PerkinElmer, it also aligns with a broader corporate culture focused on global health impact, integrity, and customer focus.
Abingdon headquarters is crucial as the origin and central hub for the development and continuous improvement of the company's core T-SPOT technology. It plays a pivotal role in Oxford Immunotec's global strategy, product supply, and scientific leadership.
As a part of PerkinElmer, Oxford Immunotec has a robust global presence, with its products utilized in over 50 countries. Key functions supported globally include sales and marketing, distribution through direct channels and partners, technical and customer support, manufacturing, and ongoing clinical research collaborations. Operations are strategically located in North America, Europe, and Asia to effectively serve diverse healthcare markets worldwide.
143 Milton Park
Abingdon
Oxfordshire
United Kingdom
Address: 500 Nickerson Road, Suite 200, Marlborough, MA 01752
To provide dedicated support and market access for Oxford Immunotec's products, particularly the T-SPOT.TB test, within the significant North American healthcare sector.
Address: Sumitomo Fudosan Hanzomon Ekimae Bldg. 8F, 1-10 Kojimachi, Chiyoda-ku, Tokyo 102-0083
To expand market penetration, ensure regulatory compliance, and provide localized expertise and support for the T-SPOT.TB test and other immunological assays in the Japanese and wider Asia-Pacific healthcare markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Oxford Immunotec' leadership includes:
Oxford Immunotec has been backed by several prominent investors over the years, including:
Specific executive changes for Oxford Immunotec as a distinct unit are integrated within PerkinElmer's broader Diagnostics division. A notable leadership appointment relevant to Oxford Immunotec within the last 12 months includes Dirk Ehlers taking the helm of PerkinElmer's Diagnostics business.
Discover the tools Oxford Immunotec uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email communication for Oxford Immunotec typically utilizes the company's domain. Common formats include a combination of the employee's first name initial and last name. Given its acquisition by PerkinElmer, some communications might also transition or be affiliated with PerkinElmer's email system, but the oxfordimmunotec.com domain remains active.
[first_initial][last]@oxfordimmunotec.com
Format
jdoe@oxfordimmunotec.com
Example
90%
Success rate
Business Wire (PerkinElmer Press Release) • April 18, 2023
PerkinElmer announced the launch of its T-Cell Select™ reagent kit. This kit is designed to automate the sample preparation workflow for Oxford Immunotec's T-SPOT®.TB test, aiming to improve laboratory efficiency, throughput, and standardization in tuberculosis screening....more
GlobeNewswire (PerkinElmer Press Release) • April 12, 2023
PerkinElmer highlighted its plans to present new clinical data and research findings related to Oxford Immunotec's T-SPOT.TB test and associated automation solutions at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, showcasing ongoing commitment to TB diagnostics....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Oxford Immunotec, are just a search away.